COVID: EVUSHELD antibody treatment soon - Khairy
The MOH will start administering treatment with the Tixagevimab and Cilgavimab (EVUSHELD) in the near future to ensure that high-risk groups continue to be protected from COVID-19 infection.
Wed Jun 08 2022
AstraZeneca says its antibody treatment failed in preventing COVID-19 in exposed patients
Participants in the trial were unvaccinated adults aged 18 and above with confirmed exposure to a person with COVID-19 within eight days.
Tue Jun 15 2021
What you need to know about the coronavirus right now
Celltrion says trial shows antibody treatment to be safe and effective COVID-19 treatment.
Mon Jun 14 2021
What you need to know about the coronavirus right now
An experimental monoclonal antibody treatment for COVID-19 being developed can "potently" neutralize numerous coronavirus variants.
Tue May 04 2021
Autoimmune-disease drugs may reduce vaccine response; antibody treatments ineffective vs Brazil variant
Here's a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19.
Tue Apr 13 2021
US approves Regeneron antibody treatment given to Trump
The treatment is for people who aren't yet hospitalized by the disease but are at high risk.
Sun Nov 22 2020
Experts raise questions about severity of Trump's COVID-19
The biggest question would be is there a risk of deterioration, or is he on a good trajectory?
Mon Oct 05 2020